3D QSAR based study of potent growth inhibitors of terpenes as antimycobacterial agents

The Open Nutraceuticals Journal 01/2011; 4:119-124.


The comparative molecular field analysis (CoMFA) based on three dimensional quantitative structure–activity relationship (3D-QSAR) studies were carried out employing, natural terpenes as potent antimycobacterial agents. The best prediction were obtained with a CoMFA standard model (q2 = 0.569, r2 = 0.999) using steric, electrostatic, hydrophobic and hydrogen bond donor fields. In the current study, a 3D QSAR model of natural product terpenes and their related derivative as antimycobacterial agents was developed. The resulted model exhibits wide-ranging in vitro potency towards
Mycobacterium tuberculosis, with minimum inhibitory concentrations (MIC) from 0.25 􀀁g/ml saringosterol through 200 g/ml diaporthein A. In order to establish structure–activity relationships, 3D-QSAR studies were carried out using CoMFA for natural terpenes (secondary metabolite of plant origin products) as potent antitubercular agents. The in vitro Minimum Inhibitory Concentration (MIC) data against M. tuberculosis (Mtb) were used. The study was conducted using twenty four compounds. A QSAR model was developed using a training set of sixteen compounds and the predictive ability of the QSAR model was assessed employing a test set of eight compounds. The resulting contour maps produced by the best CoMFA models were used to identify the structural features relevant to the biological activity in this series of natural terpenes.

Download full-text


Available from: Sanjay Mishra
  • Source
    • "There is currently a re-emerging interest in reference to drug designing as being able to provide certain novel structures for the drug discovery effort and being particularly effective as antimicrobial leads (Newman et al., 2000; Dwivedi et al., 2011). One of the major worldwide facilitators of research and development of antimicrobial drugs and their application regimes is the global alliance specifically (Pauli et al., 2005; Dwivedi et al., 2011). It is certainly exciting to see natural products being the focus of such development efforts. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Crimean-Congo hemorrhagic fever is a viral disease, widespread amongst domestic as well as wildanimals, and probably may affects humans too. This virus belonging to Bunyaviridae family containsviral RNA-dependent RNA polymerase catalyzing the biosynthesis of the RNA strands. As aconsequence of inhibition of a target enzyme protein, namely, RNA-dependent RNA polymerase there isa probability of the prevention of virus replication in the host cells. In the present investigation, RNA-dependent RNA polymerase sequence was retrieved from NCBI followed by its domain analysis to findout the effective part of the sequence later on 3D structure of the domain modeling by comparativehomology modeling approach, including a thorough screening of the homologous sequences todomain by sequence alignment technique. Template coordinates are then used as outline for modelingthe domain structure. The computed models of RNA-dependent RNA polymerase domain was validatedand then optimized by employing Ramachandran plot. Homology models of RNA-dependent RNApolymerase domain was finally taken into consideration to focus on the prediction of the specific ligandbinding site by docking against antiviral drug Ribavirin, with an aid of AutoDock4.2. The resultsobtained from the present studies provide new insights into the broad screening of certain putativemarker inhibitors of the RNA-dependent RNA polymerase concomitant with their application in therelevant drug designing.
    Full-text · Article · Apr 2012
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Phytochemicals have been the single most prolific source of leads for the development of new drug entities from the dawn of the drug discovery. They cover a wide range of therapeutic indications with a great diversity of chemical structures. The research fraternity still believes in exploring the phytochemicals for new drug discovery. Application of molecular biological techniques has increased the availability of novel compounds that can be conveniently isolated from natural sources. Combinatorial chemistry approaches are being applied based on phytochemical scaffolds to create screening libraries that closely resemble drug-like compounds. In silico techniques like quantitative structure-activity relationships (QSAR), pharmacophore and virtual screening are playing crucial and rate accelerating steps for the better drug design in modern era. Areas covered: QSAR models of different classes of phytochemicals covering different therapeutic areas are thoroughly discussed in the review. Further, the authors have enlisted all the available phytochemical databases for the convenience of researchers working in the area. Expert opinion: This review justifies the need to develop more QSAR models for the design of better drugs from phytochemicals. Technical drawbacks associated with phytochemical research have been lessened, and there are better opportunities to explore the biological activity of previously inaccessible sources of phytochemicals although there is still the need to reduce the time and cost involvement in such exercise. The future possibilities for the integration of ethnopharmacology with QSAR, place us at an exciting stage that will allow us to explore plant sources worldwide and design better drugs.
    No preview · Article · Oct 2012 · Expert Opinion on Drug Discovery